References
- Amato R. J. (2008). Vaccine therapy for renal cancer. Expert Rev Vaccines, 7, 925-35. https://doi.org/10.1586/14760584.7.7.925
- Bellone S, Pecorelli S, Cannon MJ, Santin AD (2007). Advances in dendritic-cell-based therapeutic vaccines for cervical cancer. Expert Rev Anticancer Ther, 7, 1473-86. https://doi.org/10.1586/14737140.7.10.1473
- Besch GJ, Wolberg WH, Gilchrist KW, et al (1983). A comparison of methods for the production of monodispersed cell suspensions from human primary breast carcinomas. Breast Cancer Res Treat, 3, 15-22. https://doi.org/10.1007/BF01806230
- Calderwood SK, Theriault JR.Gong J (2005). Message in a bottle, role of the 70-kDa heat shock protein family in antitumor immunity. Eur J Immunol, 35, 2518-27. https://doi.org/10.1002/eji.200535002
- Ernstoff MS, Crocenzi TS, Seigne JD (2007). Developing a rational tumor vaccine therapy for renal cell carcinoma, immune yin and yang. Clin Cancer Res, 13, 733-40. https://doi.org/10.1158/1078-0432.CCR-06-2064
- Heiser A, Maurice M. A, Yancey D. R (2001). Human dendritic cells transfected with renal tumor RNA stimulate polyclonal T-cell responses against antigens expressed by primary and metastatic tumors. Cancer Res, 61, 3388-93.
- Hu YX, Li M, Jia XH, et al (2013). HPV16 CTL Epitope Peptideactivated Dendritic Cell and Natural Killer Co-culture for Therapy of Cervical Cancer in an Animal Model. Asian Pac J Cancer Prev, 14, 7335-8. https://doi.org/10.7314/APJCP.2013.14.12.7335
- Kim F. J, Campagna A, Khandrika L. (2008). Individualized medicine for renal cell carcinoma, establishment of primary cell line culture from surgical specimens. J Endourol, 22, 2361-6. https://doi.org/10.1089/end.2008.9703
- Kuwabara K, Nishishita T, Morishita M, et al (2007). Results of a phase I clinical study using dendritic cell vaccinations for thyroid cancer. Thyroid, 17, 53-8. https://doi.org/10.1089/thy.2006.0178
- Ludewig B, Ochsenbein AF, Odermatt B, et al (2000). Immunotherapy with dendritic cells directed against tumor antigens shared with normal host cells results in severe autoimmune disease. J Exp Med, 191, 795-804. https://doi.org/10.1084/jem.191.5.795
- Mayordomo JI, Andres R, Isla MD, et al (2007). Results of a pilot trial of immunotherapy with dendritic cells pulsed with autologous tumor lysates in patients with advanced cancer. Tumori, 93, 26-30.
- Nandan D, Daubenberger C, Mpimbaza G, et al (1994). A rapid, single-step purification method for immunogenic members of the hsp 70 family, validation and application. J Immunol Methods, 176, 255-63. https://doi.org/10.1016/0022-1759(94)90319-0
- Nadeau K, Nadler SG, Saulnier M, et al (1994). Quantitation of the interaction of the immunosuppressant deoxyspergualin and analogs with Hsc70 and Hsp90. Biochemistry, 33, 2561-7. https://doi.org/10.1021/bi00175a027
- Nadler SG, Tepper MA, Schacter B, et al (1992). Interaction of the immunosuppressant deoxyspergualin with a member of the Hsp70 family of heat shock proteins. Science, 258, 484-6. https://doi.org/10.1126/science.1411548
- Passalacqua R, Buti S, Tomasello G, et al (2006). Immunotherapy options in metastatic renal cell cancer, where we are and where we are going. Expert Rev Anticancer Ther, 6, 1459-72. https://doi.org/10.1586/14737140.6.10.1459
- Peng P, Menoret A, Srivastava PK (1997). Purification of immunogenic heat shock protein 70-peptide complexes by ADP-affinity chromatography. J Immunol Methods, 204, 13-21. https://doi.org/10.1016/S0022-1759(97)00017-3
- Pinzon-Charry A, Schmidt C, Lopez JA (2006). Dendritic cell immunotherapy for breast cancer. Expert Opin Biol Ther, 6, 591-604. https://doi.org/10.1517/14712598.6.6.591
- Pittoggi C, Martis G, Mastrangeli G, et al (2008). In vitro evidence for a new therapeutic approach in renal cell carcinoma. Int Braz J Urol, 34, 492-502. https://doi.org/10.1590/S1677-55382008000400012
- Ramsey S, Aitchison M (2006). Treatment for renal cancer, are we beyond the cytokine era? Nat Clin Pract Urol, 3, 478-84.
- Srivastava P (2002). Roles of heat-shock proteins in innate and adaptive immunity. Nat Rev Immunol, 2, 185-94. https://doi.org/10.1038/nri749
- Tanriverdi O (2013). Review on targeted treatment of patients with advanced-stage renal cell carcinoma, a medical oncologist's perspective. Asian Pac J Cancer Prev, 14, 609-17. https://doi.org/10.7314/APJCP.2013.14.2.609
- Udono H.Srivastava PK (1993). Heat shock protein 70-associated peptides elicit specific cancer immunity. J Exp Med, 178, 1391-6. https://doi.org/10.1084/jem.178.4.1391
- Wierecky J, Muller MR, Wirths S, et al (2006). Immunologic and clinical responses after vaccinations with peptide-pulsed dendritic cells in metastatic renal cancer patients. Cancer Res, 66, 5910-8. https://doi.org/10.1158/0008-5472.CAN-05-3905
Cited by
- Immunogenic Effect of Hyperthermia on Enhancing Radiotherapeutic Efficacy vol.19, pp.9, 2018, https://doi.org/10.3390/ijms19092795